Xin-Yun Liu — Nantong University

Area of research

Oncology · Cancer Research

Research interest

Research focused on Pancreatic cancer and Cancer, with related work in Synthetic lethality, Olaparib, Immunotherapy. Notable publications include 'The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer', 'The power and the promise of synthetic lethality for clinical application in cancer treatment', and 'KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network'.

Recent publications

TOPBP1 as a potential predictive biomarker for enhanced combinatorial efficacy of olaparib and AZD6738 in PDAC

Cell & Bioscience 2025cited by 2position: middledoi

The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer

Journal of Advanced Research 2024cited by 17position: middledoi

The power and the promise of synthetic lethality for clinical application in cancer treatment

Biomedicine & Pharmacotherapy 2024cited by 15position: middledoi

KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network

Heliyon 2024cited by 5position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Oncology · Cancer Research →